Results 131 to 140 of about 8,310 (206)

Prevenzione e management odontoiatrico dei pazienti oncologici a rischio di osteonecrosi delle ossa mascellari da farmaci [PDF]

, 2016
non ...
Bedogni, A., Campisi, G., DI FEDE, O., Fusco, V., Mauceri, R., Panzarella, V.   +5 more
core   +1 more source

Can medication-related osteonecrosis of the jaw be attributed to specific microorganisms through oral microbiota analyses? A preliminary study

BMC Oral Health
Background Medication-related osteonecrosis of the jaw (MRONJ) can cause significant pain and loss of aesthetics and function if not treated properly. However, diagnosis still relies on detailed intraoral examinations and imaging.
Heon-Young Kim, Young-Soo Jung, Wonse Park, Yoon Jeong Choi, Jun-Young Kim   +4 more
doaj   +1 more source

Osteonecrosis de maxilares asociada al uso de bifosfonatos: revisión de 491 casos [PDF]

, 2015
En los últimos años, el número de pacientes que presenta osteonecrosis maxilar asociada al uso de bifosfonatos (BIONJ) se ha incrementado. Esto es debido al aumento en el consumo de bifosfonatos, los cuales se asocian al tratamiento de carcinomas con ...
Hernández Vigueras, Scarlette, Jané Salas, Enric, López López, José, 1958-, Pérez Tomás, Ricardo E.   +3 more
core  

Medial femoral condyle free flap for reconstructions of medication related osteonecrosis of the jaw. [PDF]

Case Reports Plast Surg Hand Surg
Wenger DC, Brown CW, Nichols PL, Tan H, Powers JM.   +4 more
europepmc   +1 more source

Radiographic Patterns and Clinical Correlates of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Retrospective Analysis. [PDF]

J Clin Med
Sevimay MA, Çetiner S.
europepmc   +1 more source

THE ROLE OF HIGH-DOSE VITAMIN D IN RISK REDUCTION OF OSTEONECROSIS OF THE JAW IN CANCER PATIENTS RECEIVING ZOLEDRONIC ACID [PDF]

Osteonecrosis of the jaw (ONJ) is a serious complication of oncological patients after or during drug therapy, whose manifestations range from asymptomatic to aspects requiring extensive operative treatment and adversely affecting patient’s qualify of ...
Giancola, Francesco
core  

Medication-Related Osteonecrosis of the Jaw: An Evidence-Based 2025 Position Statement from a Korean Multidisciplinary Task Force. [PDF]

Endocrinol Metab (Seoul)
Kim JW, Kong SH, Kim JY, Kwak MK, Kim JY, Oh JH, Park HY, Kim B, Lee YK, Han JJ, Kim MY, Choi YJ, Kwon YD, Song KS, Kim BJ, Kim SJ, Baek SH, Lee DO, Choi HS, Kim HY, Kwon TG.   +20 more
europepmc   +2 more sources

A multicenter study of CT findings in medication-related osteonecrosis of the jaw. [PDF]

Sci Rep
Otsuru M, Omori K, Hasegawa T, Yamamura Y, Kondo E, Ueda N, Soutome S, Rokutanda S, Ueda M, Nakahara H, Ishibashi K, Iwata E, Yamasaki S, Sado T, Myoken Y, Sakamoto Y, Kobayashi M, Hamana T, Kojima Y, Kanda T, Sumi M, Taguchi A, Umeda M.   +22 more
europepmc   +1 more source

Medication-related osteonecrosis of the jaw (MRONJ) [PDF]

, 2018
Alberto Bedogni, Giuseppina Campisi, Vittorio Fusco   +2 more
openaire   +2 more sources

Strategies for the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ): An Umbrella Review. [PDF]

Cureus
Gharibi A, Essadeq Z, Yamine H, Al Jalil Z, Kissa J.   +4 more
europepmc   +1 more source